Recurrent Glioblastoma Multiforme Treatment; Surgery Is the Mainstay of Treatment for Recurrent Glioblastoma Multiforme
There is no standard recurrent glioblastoma multiforme
treatment. Surgery, when feasible, is recommended, but no robust data
supporting an increase in survival are available. Glioblastoma multiforme (GBM)
is an aggressive and the most common form of brain cancer that involves glial
cells. It is a grade 4 glioma brain tumor arising from brain cells called glial
cells. A grade of a brain tumor describes how likely the tumor is to grow and
spread. Grade 4 is the most aggressive and serious type of tumor.
Glioblastoma multiforme is a heterogeneous group of tumors
(it behaves differently in different people) and can vary when it comes back or
recurs. It has a tendency to recur within 6-8 months in most patients. Although
there is no standard recurrent
glioblastoma multiforme treatment, patients with this malignancy have
many treatment options available to them. Glioblastoma’s charge their way into
normal brain tissue diffusely and erratically, which makes them surgical
nightmares. Signs and symptoms of GBM include seizures, headache, double or
blurred vision, vomiting, and difficulty in speaking.
Despite initial treatment with chemotherapy, radiotherapy
(or radiation therapy), and surgical resection, GBM virtually always recurs.
Surgery is sometimes recommended for the recurrent glioblastoma multiforme
treatment. Recurrent glioblastoma multiforme (GBM) is a possibility of
reoccurrence of glioblastoma multiforme after tumor surgery. This is because it
is difficult to remove the tumor during surgery and there is always possibility
that the cancer may occur after some time. Thus, the demand for safe and
effective recurrent glioblastoma multiforme treatment has increased worldwide.
Glioblastoma (or GBM) is one of the most complex, deadly,
and treatment-resistant cancers. Median age of diagnosis is 64 years and it is
more common in men as compared to women. According to the National Brain Tumor
Society, more than 13,000 people in the United States were expected to receive
a GBM diagnosis in 2020. Moreover, it is estimated that more than 10,000 Americans
will succumb to glioblastoma every year. The frontline treatment for GBM is
surgery, followed by radiation therapy and chemotherapy.
Comments
Post a Comment